Literature DB >> 23558563

Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes.

Donald J Messner1, Byung Han Rhieu, Kris V Kowdley.   

Abstract

BACKGROUND: Iron overload is associated with increased severity of nonalcoholic fatty liver disease (NAFLD) including progression to nonalcoholic steatohepatitis and hepatocellular carcinoma. AIMS: To identify potential role(s) of iron in NAFLD, we measured its effects on pathways of oxidative stress and insulin signaling in AML-12 mouse hepatocytes.
METHODS: Rapid iron overload was induced with 50 μM ferric ammonium citrate and 8-hydroxyquinoline. Insulin response was measured by Western blot of phospho-protein kinase B. Lipid content was determined by staining with Oil Red O. Reactive oxygen species (ROS) were measured by flow cytometry using 5-(and 6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate. Oxidative stress was measured by Western blots for phospho-jnk and phospho-p38.
RESULTS: Iron increased ROS (p < 0.001) and oxidative stress (p < 0.001) and decreased insulin signaling by 33 % (p < 0.001). Treatment with stearic or oleic acids (200 μM) increased cellular lipid content and differentially modulated effects of iron. Stearic acid potentiated iron-induced ROS levels by two-fold (p < 0.05) and further decreased insulin response 59 % (p < 0.05) versus iron alone. In contrast, cells treated with oleic acid were protected against iron-mediated injury; ROS levels were decreased by half (p < 0.01) versus iron alone while insulin response was restored to control (untreated) levels. The anti-oxidant curcumin reduced effects of iron on insulin signaling, ROS, and oxidative stress (p < 0.01). Curcumin was similarly effective in cells treated with both stearic acid and iron.
CONCLUSIONS: An in vitro model of NAFLD progression is described in which iron-induced oxidative stress inhibits insulin signaling. Pathophysiological effects of iron were increased by saturated fat and decreased by curcumin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23558563      PMCID: PMC3700657          DOI: 10.1007/s10620-013-2648-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  48 in total

1.  Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

Authors:  James E Nelson; Laura Wilson; Elizabeth M Brunt; Matthew M Yeh; David E Kleiner; Aynur Unalp-Arida; Kris V Kowdley
Journal:  Hepatology       Date:  2010-11-29       Impact factor: 17.425

Review 2.  Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.

Authors:  Katsutaro Morino; Kitt Falk Petersen; Gerald I Shulman
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

3.  Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy.

Authors:  M Grootveld; J D Bell; B Halliwell; O I Aruoma; A Bomford; P J Sadler
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

4.  Abbreviated cell cycle progression induced by the serine/threonine protein phosphatase inhibitor okadaic acid at concentrations that promote neoplastic transformation.

Authors:  D J Messner; P Ao; A B Jagdale; A L Boynton
Journal:  Carcinogenesis       Date:  2001-08       Impact factor: 4.944

5.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

6.  Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1.

Authors:  S P Cousin; S R Hügl; C E Wrede; H Kajio; M G Myers; C J Rhodes
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

7.  Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.

Authors:  Paolo Sorrentino; Salvatore D'Angelo; Umberto Ferbo; Pietro Micheli; Alessandra Bracigliano; Raffaela Vecchione
Journal:  J Hepatol       Date:  2008-11-14       Impact factor: 25.083

8.  Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O.

Authors:  J L Ramírez-Zacarías; F Castro-Muñozledo; W Kuri-Harcuch
Journal:  Histochemistry       Date:  1992-07

9.  Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form.

Authors:  Nadia Fatih; Emilie Camberlein; Marie Laure Island; Anne Corlu; Emmanuelle Abgueguen; Lénaïck Détivaud; Patricia Leroyer; Pierre Brissot; Olivier Loréal
Journal:  J Mol Med (Berl)       Date:  2010-02-19       Impact factor: 4.599

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  14 in total

1.  Hepatic Steatosis Is Associated with Elevated Serum Iron in Patients with Obesity and Improves after Laparoscopic Sleeve Gastrectomy.

Authors:  Bingwei Ma; Hang Sun; Bing Zhu; Shilin Wang; Lei Du; Xingchun Wang; Shen Qu
Journal:  Obes Facts       Date:  2020-12-22       Impact factor: 3.942

2.  Increased intracellular iron in mouse primary hepatocytes in vitro causes activation of the Akt pathway but decreases its response to insulin.

Authors:  Joe Varghese; Jithu James; Sophie Vaulont; Andrew Mckie; Molly Jacob
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-05-31       Impact factor: 3.770

3.  The Relationship between Serum Ferritin and Insulin Resistance in Different Glucose Metabolism in Nonobese Han Adults.

Authors:  Bo-Wei Liu; Xu-Min Xuan; Jun-Ru Liu; Fang-Ning Li; Fu-Zai Yin
Journal:  Int J Endocrinol       Date:  2015-08-19       Impact factor: 3.257

4.  Green tea activity and iron overload induced molecular fibrogenesis of rat liver.

Authors:  Gadah I Al-Basher
Journal:  Saudi J Biol Sci       Date:  2017-08-18       Impact factor: 4.219

5.  Curcumin and (-)- Epigallocatechin-3-Gallate Protect Murine MIN6 Pancreatic Beta-Cells Against Iron Toxicity and Erastin-Induced Ferroptosis.

Authors:  Tugba Kose; Mayra Vera-Aviles; Paul A Sharp; Gladys O Latunde-Dada
Journal:  Pharmaceuticals (Basel)       Date:  2019-02-06

6.  Variability of the transferrin receptor 2 gene in AMD.

Authors:  Daniel Wysokinski; Janusz Blasiak; Mariola Dorecka; Marta Kowalska; Jacek Robaszkiewicz; Elzbieta Pawlowska; Jerzy Szaflik; Jacek Pawel Szaflik
Journal:  Dis Markers       Date:  2014-02-06       Impact factor: 3.434

Review 7.  Iron and non-alcoholic fatty liver disease.

Authors:  Laurence J Britton; V Nathan Subramaniam; Darrell Hg Crawford
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

8.  The Relationship between Serum Ferritin Levels and Insulin Resistance in Pre- and Postmenopausal Korean Women: KNHANES 2007-2010.

Authors:  Min Kyoung Kim; Seung Joo Chon; Yeon Soo Jung; Bo Ok Kim; Eun Bee Noe; Bo Hyon Yun; SiHyun Cho; Young Sik Choi; Byung Seok Lee; Seok Kyo Seo
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

Review 9.  Sport Nutrigenomics: Personalized Nutrition for Athletic Performance.

Authors:  Nanci S Guest; Justine Horne; Shelley M Vanderhout; Ahmed El-Sohemy
Journal:  Front Nutr       Date:  2019-02-19

10.  Hepcidin Levels and Pathological Characteristics in Children with Fatty Liver Disease.

Authors:  Norito Tsutsumi; Shigeo Nishimata; Masaru Shimura; Yasuyo Kashiwagi; Hisashi Kawashima
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.